Quanyi Health Pharmacy fined in China for failure to notify Jianshengyuan Medicine deal
( October 11, 2019, 09:40 GMT | Official Statement) -- MLex Summary: Suzhou Quanyi Health Pharmacy Chain has been fined 300,000 yuan ($42,272) by China’s State Administration for Market Regulation for failing to notify its acquisition of Suzhou Jianshengyuan Medicine Chain. According to a penalty decision published today by the regulator, the deal met the statutory notification threshold, even though it had no anticompetitive impact. The regulator started a probe of the deal on April 19 and the penalty decision was dated Sept. 29.The statement follows and the penalty decision is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.